Rezaltas Combination Tablets LD contain Olmesartan medoxomil/azelnidipine, a combination used to manage high blood pressure. Manufactured by Daiichi Sankyo, this 1 tablet formulation with YJ code 2149115F1026 contains 10mg of olmesartan medoxomil and 8mg of azelnidipine.
Rezaltas Combination Tablets LD
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
